Stock Track | UnitedHealth Soars 8.77% Intraday on Strong Q2 Earnings Beat and Raised 2026 Guidance

Stock Track

Jul 16

UnitedHealth's stock surged 8.77% during intraday trading on Thursday, following the release of its second-quarter 2026 financial results that significantly exceeded analyst expectations.

The healthcare giant reported adjusted earnings per share of $6.38, beating the consensus estimate of $4.90, while revenue of $112.03 billion surpassed expectations of approximately $110.85 billion. The company also raised its full-year 2026 adjusted earnings per share guidance to a range of $19.50 to $20.00, up from its previous forecast and above analyst estimates.

The strong performance was attributed to effective medical cost controls, with the medical cost ratio improving to 86.7% compared to the expected 88.47%, and improved operations in its Optum health services segment. These results signal sustained progress in the company's turnaround efforts under CEO Stephen Hemsley, who has refocused the organization and invested in artificial intelligence initiatives to drive efficiency.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1153328450"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1153328450\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1153328450?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-16 21:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1153328450","market":"hk","top_or_hot":-1,"title":"Stock Track | UnitedHealth Soars 8.77% Intraday on Strong Q2 Earnings Beat and Raised 2026 Guidance","media":"Stock Track","content":"<p>UnitedHealth's stock surged 8.77% during intraday trading on Thursday, following the release of its second-quarter 2026 financial results that significantly exceeded analyst expectations.</p><p>The healthcare giant reported adjusted earnings per share of $6.38, beating the consensus estimate of $4.90, while revenue of $112.03 billion surpassed expectations of approximately $110.85 billion. The company also raised its full-year 2026 adjusted earnings per share guidance to a range of $19.50 to $20.00, up from its previous forecast and above analyst estimates.</p><p>The strong performance was attributed to effective medical cost controls, with the medical cost ratio improving to 86.7% compared to the expected 88.47%, and improved operations in its Optum health services segment. These results signal sustained progress in the company's turnaround efforts under CEO Stephen Hemsley, who has refocused the organization and invested in artificial intelligence initiatives to drive efficiency.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | UnitedHealth Soars 8.77% Intraday on Strong Q2 Earnings Beat and Raised 2026 Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | UnitedHealth Soars 8.77% Intraday on Strong Q2 Earnings Beat and Raised 2026 Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-07-16 21:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>UnitedHealth's stock surged 8.77% during intraday trading on Thursday, following the release of its second-quarter 2026 financial results that significantly exceeded analyst expectations.</p><p>The healthcare giant reported adjusted earnings per share of $6.38, beating the consensus estimate of $4.90, while revenue of $112.03 billion surpassed expectations of approximately $110.85 billion. The company also raised its full-year 2026 adjusted earnings per share guidance to a range of $19.50 to $20.00, up from its previous forecast and above analyst estimates.</p><p>The strong performance was attributed to effective medical cost controls, with the medical cost ratio improving to 86.7% compared to the expected 88.47%, and improved operations in its Optum health services segment. These results signal sustained progress in the company's turnaround efforts under CEO Stephen Hemsley, who has refocused the organization and invested in artificial intelligence initiatives to drive efficiency.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"UNH","symbol_name":"联合健康","start_time":0,"source_url":"","article_id":"1153328450","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1153328450","pubTimestamp":1784208935,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"UnitedHealth's stock surged 8.77% during intraday trading on Thursday, following the release of its second-quarter 2026 financial results that significantly exceeded analyst expectations.The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"UNH":"联合健康"},"translate_title":"股票跟踪 | UnitedHealth 第二季度盈利强劲并上调 2026 年指引，盘中飙升 8.77%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"UNH":1},"content_text":"UnitedHealth's stock surged 8.77% during intraday trading on Thursday, following the release of its second-quarter 2026 financial results that significantly exceeded analyst expectations.The healthcare giant reported adjusted earnings per share of $6.38, beating the consensus estimate of $4.90, while revenue of $112.03 billion surpassed expectations of approximately $110.85 billion. The company also raised its full-year 2026 adjusted earnings per share guidance to a range of $19.50 to $20.00, up from its previous forecast and above analyst estimates.The strong performance was attributed to effective medical cost controls, with the medical cost ratio improving to 86.7% compared to the expected 88.47%, and improved operations in its Optum health services segment. These results signal sustained progress in the company's turnaround efforts under CEO Stephen Hemsley, who has refocused the organization and invested in artificial intelligence initiatives to drive efficiency.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}